Attention-deficit Hyperactivity Disorder Clinical Trial
— CRAFTOfficial title:
Cognitive Restructuring in ADHD: Functional Training
Verified date | September 2019 |
Source | The Hospital for Sick Children |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of the Cognitive Restructuring in ADHD: Functional Training (CRAFT) study is to develop a non-pharmacological intervention program for children with Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a childhood onset clinical disorder of inattention, hyperactivity, and impulsivity. The present study will investigate the validity, feasibility and efficacy of this novel intervention.
Status | Completed |
Enrollment | 46 |
Est. completion date | April 17, 2017 |
Est. primary completion date | April 17, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Years to 12 Years |
Eligibility |
Inclusion Criteria: - Subject is between 6-12 years old - Subject has a diagnosis of Attention Deficit Hyperactive Disorder - Subject is a previous POND baseline study (Attention Deficit Hyperactive Disorder Cognitive deficit and syndrome definition) participant. - Parent/legal guardian and subject are willing to consent/assent to participate in this study Exclusion Criteria: - IQ below 80 on both verbal and performance scales of the Wechsler Intelligence Scale for children (WISC)-IV/V or Wechsler Abbreviated scale of intelligence (WASI II) - History of psychosis, schizophrenia or other major mental health diagnosis that will prevent participation/completion of the protocol - Subject's current medical problems that would preclude his/her participation in the study - Child younger than 6 years old or older than 12 - Parent/legal guardian and/or subject not willing to consent/assent to participate in this study |
Country | Name | City | State |
---|---|---|---|
Canada | The Hospital for Sick Children | Toronto | Ontario |
Lead Sponsor | Collaborator |
---|---|
The Hospital for Sick Children | Ehave, Ontario Brain Institute |
Canada,
Chein JM, Morrison AB. Expanding the mind's workspace: training and transfer effects with a complex working memory span task. Psychon Bull Rev. 2010 Apr;17(2):193-9. doi: 10.3758/PBR.17.2.193. — View Citation
Crosbie J, Pérusse D, Barr CL, Schachar RJ. Validating psychiatric endophenotypes: inhibitory control and attention deficit hyperactivity disorder. Neurosci Biobehav Rev. 2008;32(1):40-55. Epub 2007 May 18. Review. — View Citation
Czamara D, Tiesler CM, Kohlböck G, Berdel D, Hoffmann B, Bauer CP, Koletzko S, Schaaf B, Lehmann I, Herbarth O, von Berg A, Müller-Myhsok B, Schulte-Körne G, Heinrich J. Children with ADHD symptoms have a higher risk for reading, spelling and math difficulties in the GINIplus and LISAplus cohort studies. PLoS One. 2013 May 27;8(5):e63859. doi: 10.1371/journal.pone.0063859. Print 2013. — View Citation
Dahlin E, Nyberg L, Bäckman L, Neely AS. Plasticity of executive functioning in young and older adults: immediate training gains, transfer, and long-term maintenance. Psychol Aging. 2008 Dec;23(4):720-30. doi: 10.1037/a0014296. — View Citation
Delis DC, Kaplan E, Kramer JH. Delis-Kaplan Executive Function System (D-KEFS): Examiner's manual. San Antonio, TX: The Psychological Corporation; 2001.
Greven CU, Kovas Y, Willcutt EG, Petrill SA, Plomin R. Evidence for shared genetic risk between ADHD symptoms and reduced mathematics ability: a twin study. J Child Psychol Psychiatry. 2014 Jan;55(1):39-48. doi: 10.1111/jcpp.12090. Epub 2013 Jun 3. — View Citation
GRODZINSKY, G. M. & DIAMOND, R. 1992. Frontal lobe functioning in boys with attention-deficit hyperactivity disorder. Developmental Neuropsychology, 8, 427-445.
Hazel-Fernandez LA, Klorman R, Wallace JM, Cook S. Methylphenidate improves aspects of executive function in African American children with ADHD. J Atten Disord. 2006 May;9(4):582-9. — View Citation
Mataró M, Garcia-Sánchez C, Junqué C, Estévez-González A, Pujol J. Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioral measures. Arch Neurol. 1997 Aug;54(8):963-8. — View Citation
ROID, G. H., & LEDBETTER, M. 2006. Wide range achievement test, fourth edition - progress monitoring version. Tampa, FL: Psychological Assessment Resources. disorder. Journal of Psychophysiology, 16, 97-106.
SCHACHAR, R. J., TANNOCK, R. & LOGAN, G. 1993. Inhibitory control, impulsiveness, and attention deficit hyperactivity disorder. Clinical Psychology Review, 13, 721-739.
Schmiedeler S, Schneider W. Attention-deficit hyperactivity disorder (ADHD) in the early years: diagnostic issues and educational relevance. Clin Child Psychol Psychiatry. 2014 Jul;19(3):460-75. doi: 10.1177/1359104513489979. Epub 2013 Jun 19. — View Citation
Shue KL, Douglas VI. Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain Cogn. 1992 Sep;20(1):104-24. — View Citation
SWANSON IV, J. 2003. SNAP-IV Teacher and Parent Ratings Scale. Therapist's guide to learning and attention disorders, 487-500.
Wiers RW, Gunning WB, Sergeant JA. Is a mild deficit in executive functions in boys related to childhood ADHD or to parental multigenerational alcoholism? J Abnorm Child Psychol. 1998 Dec;26(6):415-30. — View Citation
Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005 Jun 1;57(11):1336-46. Review. — View Citation
Woodcock, R. W., McGrew, K. S., & Mather, N. (2001). Woodcock-Johnson tests of achievement III (WJ-III). Rolling Meadows, IL: Riverside Publishing.
* Note: There are 17 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Response inhibition | Inhibitory control will be measured using the Stop Signal Task. | Baseline and post-training study visits (4-5 weeks apart) | |
Primary | Change in Working memory | Target accuracy as measured by the N-Back Tasks | Baseline and post-training study visits (4-5 weeks apart) | |
Secondary | Change in Inattentive and Hyperactivity Behaviour | Measured by SNAP IV | Baseline, week1, week 2, week 3, week 4, and at post-training study visit (week 4-5) | |
Secondary | Change in Planning and Organization | will be measured using the Tower Test from the Delis-Kaplan Executive Function System | Baseline and post-training study visits (4-5 weeks apart) | |
Secondary | Change in Academic performance | Academic efficiency and accuracy will be assessed using the fluency measures from the Woodcock Johnson III (WJ III) test of achievement | Baseline and post-training study visits (4-5 weeks apart) | |
Secondary | Change in Spatial Span | We will use the spatial span item from the WISC to estimate the child's visuo-spatial span | Baseline and post-training study visits (4-5 weeks apart) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05374187 -
Efficacy of Trigeminal Nerve Stimulation for ADHD
|
N/A | |
Enrolling by invitation |
NCT04229251 -
Online Mindfulness-Based Intervention for ADHD
|
N/A | |
Completed |
NCT00339729 -
Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT04416360 -
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak
|
N/A | |
Recruiting |
NCT01657721 -
Working Memory Training in ADHD (The Engage Study)
|
Phase 1 | |
Completed |
NCT04786730 -
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT01323192 -
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
|
Phase 3 | |
Recruiting |
NCT05165511 -
Families, Responsibility, Education, Support, and Health for Executive Function
|
N/A | |
Completed |
NCT01886469 -
A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1/Phase 2 | |
Completed |
NCT01010750 -
Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1 | |
Recruiting |
NCT04729439 -
Technology-Enhanced Executive Functioning Intervention for ADHD
|
Phase 1 | |
Completed |
NCT01624649 -
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
|
Phase 4 | |
Completed |
NCT03806946 -
Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder
|
||
Recruiting |
NCT05869253 -
The Efficacy of Equine Assisted Occupational Therapy, for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation
|
N/A | |
Completed |
NCT01907360 -
Pharmacokinetics of HLD200 in Children and Adolescents With ADHD
|
Phase 1/Phase 2 |